| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcus agalactiae | 4 | 2011 | 375 | 1.080 |
Why?
|
| Heart Conduction System | 12 | 2017 | 1048 | 0.690 |
Why?
|
| Cardiomyopathy, Hypertrophic | 8 | 2023 | 1263 | 0.600 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 2008 | 143 | 0.590 |
Why?
|
| Keratoacanthoma | 1 | 2016 | 32 | 0.580 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2016 | 127 | 0.550 |
Why?
|
| Cardiomyopathy, Dilated | 6 | 2023 | 851 | 0.540 |
Why?
|
| Myocytes, Cardiac | 18 | 2023 | 1636 | 0.540 |
Why?
|
| Myocardium | 16 | 2020 | 4775 | 0.540 |
Why?
|
| Cardiomyopathies | 10 | 2022 | 1912 | 0.500 |
Why?
|
| Homeodomain Proteins | 11 | 2015 | 2417 | 0.500 |
Why?
|
| Streptavidin | 1 | 2014 | 81 | 0.490 |
Why?
|
| Serotyping | 2 | 2011 | 338 | 0.450 |
Why?
|
| Dependovirus | 3 | 2016 | 706 | 0.430 |
Why?
|
| DNA, Single-Stranded | 1 | 2014 | 353 | 0.430 |
Why?
|
| Gene Transfer Techniques | 3 | 2016 | 1224 | 0.410 |
Why?
|
| Myosin Heavy Chains | 4 | 2020 | 414 | 0.410 |
Why?
|
| Streptococcal Infections | 2 | 2005 | 637 | 0.380 |
Why?
|
| Sarcomeres | 6 | 2022 | 374 | 0.370 |
Why?
|
| Herpes Simplex | 3 | 2022 | 466 | 0.360 |
Why?
|
| Indoles | 2 | 2016 | 1834 | 0.330 |
Why?
|
| Simplexvirus | 5 | 2022 | 802 | 0.330 |
Why?
|
| Fibrosis | 8 | 2022 | 2026 | 0.330 |
Why?
|
| Meningeal Neoplasms | 6 | 2023 | 1241 | 0.320 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2005 | 1320 | 0.320 |
Why?
|
| Tachycardia | 2 | 2001 | 620 | 0.310 |
Why?
|
| Complement Inactivator Proteins | 3 | 2004 | 79 | 0.310 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 3504 | 0.310 |
Why?
|
| Cardiac Myosins | 2 | 2020 | 117 | 0.310 |
Why?
|
| Meningioma | 5 | 2023 | 1209 | 0.300 |
Why?
|
| Sulfonamides | 1 | 2016 | 1932 | 0.290 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 2 | 2017 | 66 | 0.290 |
Why?
|
| RNA | 3 | 2023 | 2747 | 0.280 |
Why?
|
| Myocardial Contraction | 6 | 2020 | 1585 | 0.280 |
Why?
|
| Electrocardiography | 20 | 2017 | 6440 | 0.270 |
Why?
|
| Xenopus Proteins | 4 | 2003 | 433 | 0.270 |
Why?
|
| Atrioventricular Node | 6 | 2007 | 182 | 0.270 |
Why?
|
| Transcription Factors | 10 | 2020 | 12164 | 0.260 |
Why?
|
| Single-Cell Analysis | 3 | 2022 | 2183 | 0.260 |
Why?
|
| Mice | 54 | 2023 | 81045 | 0.250 |
Why?
|
| Calcium-Binding Proteins | 2 | 2020 | 1081 | 0.240 |
Why?
|
| Mutation, Missense | 6 | 2023 | 2556 | 0.230 |
Why?
|
| Electrophysiology | 9 | 2007 | 1309 | 0.230 |
Why?
|
| Heart Defects, Congenital | 7 | 2016 | 4566 | 0.230 |
Why?
|
| Muscle Proteins | 2 | 2022 | 1159 | 0.230 |
Why?
|
| Animals | 65 | 2023 | 168561 | 0.220 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2022 | 76 | 0.210 |
Why?
|
| Melanoma | 2 | 2020 | 5462 | 0.210 |
Why?
|
| Cyclophosphamide | 4 | 2004 | 2236 | 0.210 |
Why?
|
| Viruses | 2 | 2003 | 374 | 0.200 |
Why?
|
| Bradycardia | 1 | 2003 | 305 | 0.200 |
Why?
|
| Genetic Vectors | 8 | 2015 | 3420 | 0.200 |
Why?
|
| Oncolytic Virotherapy | 2 | 2023 | 490 | 0.200 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2021 | 52 | 0.200 |
Why?
|
| Skin Neoplasms | 2 | 2020 | 5662 | 0.200 |
Why?
|
| Disease Models, Animal | 20 | 2022 | 18006 | 0.190 |
Why?
|
| Solitary Nucleus | 1 | 2021 | 63 | 0.190 |
Why?
|
| Nuclear Proteins | 6 | 2020 | 5851 | 0.190 |
Why?
|
| Herpesvirus 1, Human | 2 | 2003 | 742 | 0.190 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2022 | 161 | 0.190 |
Why?
|
| Osteitis | 1 | 2020 | 33 | 0.190 |
Why?
|
| Oncolytic Viruses | 2 | 2023 | 323 | 0.190 |
Why?
|
| Glioblastoma | 3 | 2023 | 3456 | 0.190 |
Why?
|
| Hair | 1 | 2023 | 483 | 0.180 |
Why?
|
| Alopecia | 1 | 2023 | 381 | 0.170 |
Why?
|
| YY1 Transcription Factor | 1 | 2019 | 60 | 0.170 |
Why?
|
| Carrier Proteins | 6 | 2022 | 5019 | 0.170 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2019 | 96 | 0.170 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2019 | 112 | 0.170 |
Why?
|
| Gene Expression Profiling | 5 | 2020 | 9410 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2016 | 3617 | 0.170 |
Why?
|
| Cardiomegaly | 3 | 2021 | 619 | 0.160 |
Why?
|
| Mutation | 19 | 2023 | 29717 | 0.160 |
Why?
|
| Connexins | 5 | 2004 | 359 | 0.160 |
Why?
|
| Heart | 8 | 2017 | 4462 | 0.160 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 3585 | 0.160 |
Why?
|
| Azepines | 1 | 2020 | 336 | 0.160 |
Why?
|
| Heart Ventricles | 7 | 2022 | 3801 | 0.150 |
Why?
|
| Interleukin-11 | 1 | 2017 | 62 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2016 | 608 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2019 | 987 | 0.150 |
Why?
|
| Myosins | 1 | 2019 | 409 | 0.150 |
Why?
|
| Acantholysis | 1 | 2016 | 11 | 0.150 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 13655 | 0.150 |
Why?
|
| Mice, Transgenic | 10 | 2019 | 9735 | 0.140 |
Why?
|
| Cell Nucleus | 3 | 2022 | 2968 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2017 | 644 | 0.140 |
Why?
|
| Facial Dermatoses | 1 | 2016 | 87 | 0.140 |
Why?
|
| Genetic Engineering | 2 | 2016 | 952 | 0.140 |
Why?
|
| RNA Interference | 2 | 2016 | 2890 | 0.140 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2022 | 1728 | 0.130 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2019 | 670 | 0.130 |
Why?
|
| Adenosine Triphosphatases | 2 | 2020 | 836 | 0.130 |
Why?
|
| Arrhythmias, Cardiac | 7 | 2021 | 2267 | 0.130 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2021 | 859 | 0.130 |
Why?
|
| Protein Kinases | 1 | 2022 | 1638 | 0.130 |
Why?
|
| Gene Expression | 6 | 2016 | 7790 | 0.130 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2023 | 895 | 0.130 |
Why?
|
| Benzylamines | 1 | 2016 | 226 | 0.130 |
Why?
|
| Uracil | 1 | 2016 | 164 | 0.130 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 4 | 2015 | 489 | 0.130 |
Why?
|
| Triazoles | 1 | 2020 | 907 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2002 | 2751 | 0.120 |
Why?
|
| Calcium Channel Blockers | 2 | 2010 | 689 | 0.120 |
Why?
|
| Mice, Inbred Strains | 6 | 2016 | 1827 | 0.120 |
Why?
|
| RNA, Messenger | 5 | 2022 | 13029 | 0.120 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 1707 | 0.120 |
Why?
|
| Cytokinesis | 1 | 2015 | 177 | 0.120 |
Why?
|
| Transduction, Genetic | 2 | 2016 | 913 | 0.120 |
Why?
|
| Heterozygote | 7 | 2016 | 2790 | 0.120 |
Why?
|
| Atrioventricular Block | 1 | 2015 | 120 | 0.120 |
Why?
|
| Calcium Channels | 1 | 2017 | 621 | 0.120 |
Why?
|
| Nervous System Malformations | 1 | 2015 | 245 | 0.120 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2005 | 2026 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 12 | 2020 | 21821 | 0.110 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2010 | 790 | 0.110 |
Why?
|
| Connexin 43 | 4 | 2017 | 206 | 0.110 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4200 | 0.110 |
Why?
|
| Ventricular Dysfunction | 1 | 2013 | 143 | 0.110 |
Why?
|
| Tachycardia, Ventricular | 5 | 2010 | 1272 | 0.110 |
Why?
|
| Glycogen | 2 | 2016 | 260 | 0.110 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2013 | 242 | 0.100 |
Why?
|
| Psoriasis | 1 | 2020 | 898 | 0.100 |
Why?
|
| Neoplasm Proteins | 4 | 2001 | 3691 | 0.100 |
Why?
|
| Humans | 61 | 2023 | 742088 | 0.100 |
Why?
|
| Body Surface Potential Mapping | 3 | 2004 | 238 | 0.100 |
Why?
|
| Lamin Type A | 2 | 2015 | 190 | 0.100 |
Why?
|
| Iodide Peroxidase | 1 | 2013 | 293 | 0.100 |
Why?
|
| Hand Deformities, Congenital | 1 | 2012 | 145 | 0.100 |
Why?
|
| Telemetry | 4 | 2009 | 205 | 0.100 |
Why?
|
| Astrocytoma | 1 | 1996 | 789 | 0.100 |
Why?
|
| SOS1 Protein | 1 | 2010 | 41 | 0.100 |
Why?
|
| Calsequestrin | 1 | 2010 | 30 | 0.100 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2010 | 106 | 0.090 |
Why?
|
| Mice, Knockout | 10 | 2020 | 14554 | 0.090 |
Why?
|
| Heart Rate | 8 | 2002 | 4091 | 0.090 |
Why?
|
| Calcium | 3 | 2021 | 5753 | 0.090 |
Why?
|
| Infant, Newborn | 6 | 2016 | 25575 | 0.090 |
Why?
|
| Cardiovascular System | 1 | 2017 | 827 | 0.090 |
Why?
|
| Noonan Syndrome | 1 | 2010 | 120 | 0.090 |
Why?
|
| Verapamil | 1 | 2010 | 244 | 0.090 |
Why?
|
| Complement System Proteins | 3 | 2003 | 795 | 0.090 |
Why?
|
| Alleles | 4 | 2016 | 6931 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3639 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 692 | 0.090 |
Why?
|
| Down-Regulation | 4 | 2009 | 3001 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 4 | 2021 | 2011 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2015 | 829 | 0.080 |
Why?
|
| Rats, Nude | 3 | 2004 | 105 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 1 | 2009 | 151 | 0.080 |
Why?
|
| Cytokines | 1 | 2004 | 7317 | 0.080 |
Why?
|
| Virus Replication | 4 | 2006 | 2531 | 0.080 |
Why?
|
| Female | 40 | 2023 | 379592 | 0.080 |
Why?
|
| Penicillins | 1 | 2011 | 378 | 0.080 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2001 | 846 | 0.080 |
Why?
|
| Brain Neoplasms | 6 | 2004 | 8829 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2004 | 4414 | 0.080 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2002 | 475 | 0.080 |
Why?
|
| Mice, Mutant Strains | 5 | 2017 | 1866 | 0.080 |
Why?
|
| Heart Atria | 3 | 2020 | 1348 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 4 | 2013 | 5867 | 0.080 |
Why?
|
| Adenoviridae | 5 | 2003 | 1096 | 0.080 |
Why?
|
| Restriction Mapping | 1 | 2008 | 878 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 2 | 2005 | 7153 | 0.080 |
Why?
|
| Male | 41 | 2023 | 349538 | 0.080 |
Why?
|
| Glycogen Storage Disease | 1 | 2007 | 41 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 3 | 2014 | 6171 | 0.070 |
Why?
|
| Huntington Disease | 1 | 2013 | 1111 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2013 | 2215 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 12071 | 0.070 |
Why?
|
| Aging | 2 | 2023 | 8626 | 0.070 |
Why?
|
| Pheochromocytoma | 1 | 2009 | 337 | 0.070 |
Why?
|
| Histones | 2 | 2015 | 2597 | 0.070 |
Why?
|
| Macrophages | 2 | 2020 | 5655 | 0.070 |
Why?
|
| Meningitis, Bacterial | 1 | 2008 | 218 | 0.070 |
Why?
|
| Mice, 129 Strain | 2 | 2019 | 386 | 0.070 |
Why?
|
| Environment | 1 | 2012 | 1115 | 0.070 |
Why?
|
| Haploinsufficiency | 2 | 2019 | 329 | 0.070 |
Why?
|
| Calcium Signaling | 1 | 2010 | 721 | 0.070 |
Why?
|
| Rats | 8 | 2016 | 24265 | 0.060 |
Why?
|
| Arrhythmia, Sinus | 1 | 2005 | 56 | 0.060 |
Why?
|
| Rats, Inbred F344 | 2 | 2004 | 862 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 1871 | 0.060 |
Why?
|
| Autonomic Nervous System | 3 | 2013 | 671 | 0.060 |
Why?
|
| Bundle-Branch Block | 2 | 2004 | 270 | 0.060 |
Why?
|
| Neoplasms | 3 | 2019 | 21596 | 0.060 |
Why?
|
| Phenotype | 7 | 2019 | 16331 | 0.060 |
Why?
|
| Ventricular Fibrillation | 2 | 2004 | 538 | 0.060 |
Why?
|
| Glucose | 2 | 2013 | 4391 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5163 | 0.060 |
Why?
|
| Isoproterenol | 1 | 2004 | 399 | 0.060 |
Why?
|
| Echocardiography | 5 | 2009 | 5097 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2019 | 6540 | 0.060 |
Why?
|
| Fibroblasts | 3 | 2020 | 4143 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 686 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2906 | 0.060 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2000 | 578 | 0.060 |
Why?
|
| Callithrix | 1 | 2003 | 93 | 0.060 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2009 | 740 | 0.060 |
Why?
|
| Pregnancy | 5 | 2011 | 29087 | 0.060 |
Why?
|
| Heart Failure | 3 | 2022 | 10856 | 0.060 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2003 | 60 | 0.060 |
Why?
|
| Nitrites | 1 | 2003 | 160 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 438 | 0.050 |
Why?
|
| Models, Animal | 3 | 2006 | 2170 | 0.050 |
Why?
|
| Homeostasis | 3 | 2020 | 3335 | 0.050 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2004 | 346 | 0.050 |
Why?
|
| Nucleoproteins | 1 | 2023 | 115 | 0.050 |
Why?
|
| Ventricular Myosins | 1 | 2002 | 50 | 0.050 |
Why?
|
| Energy Metabolism | 2 | 2020 | 2896 | 0.050 |
Why?
|
| Endocardium | 1 | 2003 | 261 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 2006 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2001 | 5019 | 0.050 |
Why?
|
| Glioma | 3 | 2004 | 3388 | 0.050 |
Why?
|
| Ki-67 Antigen | 4 | 1999 | 644 | 0.050 |
Why?
|
| Glycogen Storage Disease Type IIb | 1 | 2021 | 18 | 0.050 |
Why?
|
| Heart Block | 1 | 2003 | 410 | 0.050 |
Why?
|
| Heart Diseases | 2 | 2013 | 2789 | 0.050 |
Why?
|
| Transgenes | 3 | 2017 | 1009 | 0.050 |
Why?
|
| Nitrates | 1 | 2003 | 265 | 0.050 |
Why?
|
| Hair Follicle | 1 | 2023 | 209 | 0.050 |
Why?
|
| Death, Sudden | 1 | 2003 | 298 | 0.050 |
Why?
|
| Cells, Cultured | 5 | 2020 | 19223 | 0.050 |
Why?
|
| Cell Transplantation | 1 | 2023 | 477 | 0.050 |
Why?
|
| Endothelial Cells | 3 | 2022 | 3455 | 0.050 |
Why?
|
| Cholinergic Agonists | 1 | 2001 | 74 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 2015 | 0.050 |
Why?
|
| Atlases as Topic | 1 | 2022 | 237 | 0.050 |
Why?
|
| Carbachol | 1 | 2001 | 226 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 2 | 2013 | 418 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4751 | 0.050 |
Why?
|
| Multiple Organ Failure | 1 | 2003 | 389 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2022 | 568 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2001 | 251 | 0.050 |
Why?
|
| Physical Endurance | 1 | 2002 | 370 | 0.040 |
Why?
|
| Cell Separation | 2 | 2021 | 1749 | 0.040 |
Why?
|
| Muscle Relaxation | 1 | 2020 | 142 | 0.040 |
Why?
|
| Atrial Function | 1 | 2000 | 107 | 0.040 |
Why?
|
| Animals, Newborn | 3 | 2015 | 2723 | 0.040 |
Why?
|
| Neoplasm Transplantation | 4 | 2009 | 2085 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2013 | 3861 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2002 | 585 | 0.040 |
Why?
|
| Oximes | 1 | 2020 | 309 | 0.040 |
Why?
|
| Gap Junctions | 1 | 2000 | 233 | 0.040 |
Why?
|
| Propranolol | 3 | 2010 | 502 | 0.040 |
Why?
|
| Middle Aged | 13 | 2019 | 213127 | 0.040 |
Why?
|
| Signal Transduction | 5 | 2016 | 23387 | 0.040 |
Why?
|
| Empyema, Subdural | 1 | 1998 | 12 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 916 | 0.040 |
Why?
|
| Hemangiopericytoma | 1 | 1998 | 77 | 0.040 |
Why?
|
| Motor Activity | 2 | 2013 | 2714 | 0.040 |
Why?
|
| Cancer Vaccines | 1 | 2006 | 1021 | 0.040 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 15 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2020 | 370 | 0.040 |
Why?
|
| Angiotensin Amide | 1 | 2017 | 4 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 1999 | 2948 | 0.040 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 4455 | 0.040 |
Why?
|
| Cardiotonic Agents | 1 | 2001 | 535 | 0.040 |
Why?
|
| Ventricular Function | 1 | 2000 | 416 | 0.040 |
Why?
|
| Pericytes | 1 | 2020 | 291 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2003 | 609 | 0.040 |
Why?
|
| Mouth | 1 | 2020 | 373 | 0.040 |
Why?
|
| Brain Abscess | 1 | 1998 | 118 | 0.040 |
Why?
|
| Nucleoside Deaminases | 1 | 1997 | 58 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2022 | 789 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 1135 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 413 | 0.040 |
Why?
|
| Mitochondria, Liver | 1 | 2017 | 187 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2017 | 171 | 0.040 |
Why?
|
| alpha-Fetoproteins | 1 | 1997 | 222 | 0.030 |
Why?
|
| Defective Viruses | 1 | 1996 | 112 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2012 | 17400 | 0.030 |
Why?
|
| Pyridones | 1 | 2020 | 712 | 0.030 |
Why?
|
| Muscle Cells | 1 | 2016 | 196 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2003 | 1354 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 1996 | 1799 | 0.030 |
Why?
|
| Epithelium | 1 | 2020 | 1680 | 0.030 |
Why?
|
| Thymidine Kinase | 1 | 1996 | 290 | 0.030 |
Why?
|
| Time Factors | 6 | 2016 | 40054 | 0.030 |
Why?
|
| RNA Splicing | 2 | 2015 | 907 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 5 | 2009 | 6313 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1996 | 259 | 0.030 |
Why?
|
| Adult | 13 | 2022 | 213712 | 0.030 |
Why?
|
| Proteins | 1 | 2010 | 6096 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2020 | 1353 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2015 | 194 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2019 | 1663 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 1737 | 0.030 |
Why?
|
| Calcineurin | 1 | 2015 | 226 | 0.030 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1996 | 347 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 331 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2017 | 645 | 0.030 |
Why?
|
| 5' Flanking Region | 1 | 2014 | 31 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2017 | 881 | 0.030 |
Why?
|
| Imidazoles | 1 | 2020 | 1205 | 0.030 |
Why?
|
| Child | 8 | 2022 | 77478 | 0.030 |
Why?
|
| Codon, Initiator | 1 | 2014 | 52 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2013 | 64 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2013 | 126 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 2009 | 1581 | 0.030 |
Why?
|
| Cell Division | 3 | 1996 | 4564 | 0.030 |
Why?
|
| Automatism | 1 | 1993 | 9 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 2715 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2009 | 8541 | 0.030 |
Why?
|
| Epilepsy, Frontal Lobe | 1 | 1993 | 26 | 0.030 |
Why?
|
| Adipocytes | 1 | 2020 | 1182 | 0.030 |
Why?
|
| Autophagy | 1 | 2021 | 1301 | 0.030 |
Why?
|
| Genes, Developmental | 1 | 2013 | 40 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2013 | 266 | 0.030 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2013 | 192 | 0.030 |
Why?
|
| Immunosuppressive Agents | 2 | 2003 | 4147 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 1995 | 414 | 0.030 |
Why?
|
| Cell Differentiation | 3 | 2016 | 11470 | 0.030 |
Why?
|
| Ventricular Remodeling | 2 | 2015 | 1224 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2022 | 9185 | 0.030 |
Why?
|
| Electric Stimulation | 3 | 2003 | 1770 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 2024 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1996 | 640 | 0.030 |
Why?
|
| Homozygote | 2 | 2010 | 1777 | 0.030 |
Why?
|
| Pressure | 1 | 2015 | 1203 | 0.030 |
Why?
|
| Mortality | 1 | 2003 | 2857 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2440 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 2 | 2010 | 1525 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2020 | 4013 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2015 | 8436 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 2885 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 3444 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 2749 | 0.030 |
Why?
|
| Smell | 1 | 2013 | 243 | 0.030 |
Why?
|
| Disease Susceptibility | 3 | 2003 | 1780 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2013 | 494 | 0.020 |
Why?
|
| Kidney | 3 | 2017 | 7167 | 0.020 |
Why?
|
| Melanoma, Experimental | 1 | 1995 | 559 | 0.020 |
Why?
|
| Apoptosis | 1 | 2007 | 9715 | 0.020 |
Why?
|
| Genotype | 2 | 2023 | 12946 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1995 | 902 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2020 | 1780 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3557 | 0.020 |
Why?
|
| Cell Count | 1 | 2015 | 1831 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3564 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 1376 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 1995 | 952 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2001 | 4197 | 0.020 |
Why?
|
| Atropine | 2 | 2001 | 244 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 1995 | 1097 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 2015 | 707 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2020 | 2028 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2010 | 158 | 0.020 |
Why?
|
| Methylation | 1 | 2013 | 1107 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2015 | 1684 | 0.020 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2010 | 163 | 0.020 |
Why?
|
| Diltiazem | 1 | 2010 | 133 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2010 | 322 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 2126 | 0.020 |
Why?
|
| Metabolome | 1 | 2016 | 881 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 2 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Receptors, Melanocortin | 1 | 2009 | 25 | 0.020 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2010 | 176 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2009 | 235 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2009 | 195 | 0.020 |
Why?
|
| Plasmids | 2 | 2006 | 2305 | 0.020 |
Why?
|
| Hypertension | 1 | 2009 | 8455 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2009 | 51 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1995 | 1504 | 0.020 |
Why?
|
| Fetus | 1 | 2016 | 1879 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2009 | 129 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2023 | 4282 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2009 | 330 | 0.020 |
Why?
|
| Aorta | 1 | 2016 | 2057 | 0.020 |
Why?
|
| Losartan | 1 | 2010 | 298 | 0.020 |
Why?
|
| Lysine | 1 | 2013 | 1008 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 2013 | 15108 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3678 | 0.020 |
Why?
|
| Cell Survival | 2 | 2016 | 5872 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 1613 | 0.020 |
Why?
|
| Catecholamines | 1 | 2009 | 387 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2010 | 5180 | 0.020 |
Why?
|
| Action Potentials | 2 | 2008 | 1814 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 1911 | 0.020 |
Why?
|
| Substrate Cycling | 1 | 2007 | 8 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2016 | 2504 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2013 | 5978 | 0.020 |
Why?
|
| Adolescent | 5 | 2016 | 85649 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9639 | 0.020 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2009 | 281 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 1723 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2015 | 10472 | 0.020 |
Why?
|
| Prognosis | 3 | 2015 | 29010 | 0.020 |
Why?
|
| Magnesium | 1 | 2010 | 813 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2016 | 21719 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2699 | 0.020 |
Why?
|
| Social Behavior | 1 | 2013 | 1128 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1538 | 0.020 |
Why?
|
| Protein Binding | 1 | 2019 | 9387 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 3770 | 0.020 |
Why?
|
| Polysomnography | 1 | 1993 | 1772 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 643 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 1337 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 1899 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2016 | 1877 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 1996 | 1327 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 874 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 1547 | 0.020 |
Why?
|
| Chemokine CCL21 | 1 | 2006 | 51 | 0.020 |
Why?
|
| Chickens | 1 | 2008 | 865 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2009 | 909 | 0.020 |
Why?
|
| Genes, p53 | 2 | 1999 | 755 | 0.020 |
Why?
|
| Necrosis | 1 | 2010 | 1643 | 0.020 |
Why?
|
| Prevalence | 1 | 2023 | 15194 | 0.020 |
Why?
|
| Models, Cardiovascular | 2 | 2001 | 994 | 0.020 |
Why?
|
| Disease Progression | 3 | 2015 | 13256 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 1882 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2013 | 10248 | 0.020 |
Why?
|
| Aged | 7 | 2019 | 162944 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2012 | 1780 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 4933 | 0.020 |
Why?
|
| Vero Cells | 1 | 2006 | 485 | 0.020 |
Why?
|
| Point Mutation | 1 | 2010 | 1624 | 0.020 |
Why?
|
| Chemokines, CC | 1 | 2006 | 291 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2001 | 8425 | 0.020 |
Why?
|
| Probability | 2 | 2000 | 2502 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 1887 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2010 | 1239 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 2502 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1997 | 2211 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2015 | 3020 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 1986 | 277 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 4187 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2006 | 526 | 0.020 |
Why?
|
| Learning | 1 | 2013 | 1705 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2009 | 1158 | 0.010 |
Why?
|
| Long QT Syndrome | 1 | 2008 | 453 | 0.010 |
Why?
|
| Liver | 2 | 2013 | 7470 | 0.010 |
Why?
|
| Carboxypeptidases | 1 | 2003 | 176 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 2007 | 557 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1986 | 709 | 0.010 |
Why?
|
| Tretinoin | 1 | 1986 | 516 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 2006 | 6382 | 0.010 |
Why?
|
| Reference Values | 2 | 2000 | 4982 | 0.010 |
Why?
|
| Child, Preschool | 4 | 2016 | 40955 | 0.010 |
Why?
|
| APACHE | 1 | 2003 | 277 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2006 | 1146 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 1792 | 0.010 |
Why?
|
| Sympatholytics | 1 | 2001 | 83 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1996 | 9274 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 2001 | 91 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2003 | 365 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 7721 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 12220 | 0.010 |
Why?
|
| Chromatin | 1 | 2013 | 2917 | 0.010 |
Why?
|
| Neurons | 1 | 2020 | 9325 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1997 | 4249 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2007 | 3701 | 0.010 |
Why?
|
| Age of Onset | 1 | 2007 | 3266 | 0.010 |
Why?
|
| Infant | 3 | 2016 | 35070 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2009 | 4742 | 0.010 |
Why?
|
| Digoxin | 1 | 2001 | 250 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 2000 | 40 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 4465 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3920 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2013 | 9846 | 0.010 |
Why?
|
| Bundle of His | 1 | 2000 | 88 | 0.010 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2001 | 194 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2001 | 534 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11472 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2001 | 11690 | 0.010 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2001 | 393 | 0.010 |
Why?
|
| Baroreflex | 1 | 2000 | 146 | 0.010 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2000 | 137 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2002 | 963 | 0.010 |
Why?
|
| Anxiety | 1 | 2013 | 4279 | 0.010 |
Why?
|
| Brain | 4 | 2015 | 26343 | 0.010 |
Why?
|
| Vasodilation | 1 | 2003 | 944 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2001 | 689 | 0.010 |
Why?
|
| Models, Biological | 1 | 2015 | 9581 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 1213 | 0.010 |
Why?
|
| Virus Activation | 1 | 2000 | 319 | 0.010 |
Why?
|
| Electrodes | 1 | 2000 | 615 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 3248 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2007 | 4211 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 8300 | 0.010 |
Why?
|
| Potassium | 1 | 2002 | 1336 | 0.010 |
Why?
|
| Survival Rate | 2 | 2003 | 12773 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2001 | 1526 | 0.010 |
Why?
|
| Vascular Neoplasms | 1 | 1998 | 175 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 1950 | 0.010 |
Why?
|
| Cytosine Deaminase | 1 | 1997 | 68 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2023 | 62966 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 40450 | 0.010 |
Why?
|
| Organ Size | 1 | 2001 | 2253 | 0.010 |
Why?
|
| Species Specificity | 1 | 2000 | 2479 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 3081 | 0.010 |
Why?
|
| Family Health | 1 | 2001 | 1282 | 0.010 |
Why?
|
| Observer Variation | 1 | 2001 | 2593 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1998 | 20086 | 0.010 |
Why?
|
| Lung | 1 | 2013 | 9826 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2001 | 11363 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1999 | 1402 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2019 | 53187 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1999 | 1538 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 4246 | 0.010 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1993 | 49 | 0.010 |
Why?
|
| Actins | 1 | 2001 | 2120 | 0.010 |
Why?
|
| Exons | 1 | 1999 | 2431 | 0.010 |
Why?
|
| Phenytoin | 1 | 1993 | 197 | 0.010 |
Why?
|
| Carbamazepine | 1 | 1993 | 229 | 0.010 |
Why?
|
| Retroviridae | 1 | 1995 | 914 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 19862 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 1998 | 759 | 0.010 |
Why?
|
| Brain Edema | 1 | 1995 | 617 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 1999 | 3612 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3800 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 77098 | 0.010 |
Why?
|
| Body Weight | 1 | 2001 | 4664 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 1993 | 545 | 0.010 |
Why?
|
| Catheterization | 1 | 1995 | 1468 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 56350 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2001 | 2059 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 15494 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1996 | 3127 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2000 | 2585 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 10392 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 16665 | 0.010 |
Why?
|
| Rabbits | 1 | 1995 | 4886 | 0.010 |
Why?
|
| Sleep Stages | 1 | 1993 | 686 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1999 | 3164 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1999 | 4328 | 0.000 |
Why?
|
| Immunity, Innate | 1 | 1999 | 2956 | 0.000 |
Why?
|
| Evoked Potentials | 1 | 1993 | 1057 | 0.000 |
Why?
|
| Receptors, Estrogen | 1 | 1995 | 2186 | 0.000 |
Why?
|
| Neurosurgical Procedures | 1 | 1998 | 2002 | 0.000 |
Why?
|
| Lactalbumin | 1 | 1986 | 21 | 0.000 |
Why?
|
| Uterine Neoplasms | 1 | 1996 | 1513 | 0.000 |
Why?
|
| Frontal Lobe | 1 | 1993 | 1407 | 0.000 |
Why?
|
| Thymidine | 1 | 1986 | 309 | 0.000 |
Why?
|
| Vaccines | 1 | 1995 | 817 | 0.000 |
Why?
|
| Caseins | 1 | 1986 | 103 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 2003 | 57683 | 0.000 |
Why?
|
| Risk Factors | 1 | 2012 | 72145 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 15530 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 14720 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 6608 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1986 | 964 | 0.000 |
Why?
|
| Age Factors | 1 | 2001 | 18355 | 0.000 |
Why?
|
| Decision Making | 1 | 1998 | 3869 | 0.000 |
Why?
|
| Prolactin | 1 | 1986 | 669 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1993 | 6483 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 15056 | 0.000 |
Why?
|
| Vaccination | 1 | 1995 | 3256 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1986 | 1791 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1995 | 12958 | 0.000 |
Why?
|
| DNA Replication | 1 | 1986 | 1397 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1986 | 1825 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1998 | 13019 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1986 | 10943 | 0.000 |
Why?
|
| Insulin | 1 | 1986 | 6575 | 0.000 |
Why?
|